Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Recombinant Factor IX Product, IB1001, in Previously Treated Pediatric Subjects With Hemophilia B

NCT01271868 is registered in ClinicalTrials.gov with Medexus Pharma, Inc. as lead sponsor.

NCT NCT01271868
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01271868 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Recombinant Factor IX Product, IB1001, in Previously Treated Pediatric Subjects With Hemophilia B
Lead sponsor
Medexus Pharma, Inc.
Phase
Phase 3
Overall status
Terminated
Start date
November 30, 2010
Completion date
December 31, 2016
Enrollment
9 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

hemophilia b